AbCellera Biologics (ABCL)
(Delayed Data from NSDQ)
$3.76 USD
+0.13 (3.58%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.76 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/7/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.17 |
Last EPS Surprise | -21.43% |
ABR | 1.00 |
Earnings ESP
|
20.73% |
---|---|
Current Year | -0.66 |
Next Year | -0.70 |
EPS (TTM) | -0.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.27M | 12.25M | 49.39M | 68.06M |
# of Estimates | 7 | 5 | 7 | 7 |
High Estimate | 18.29M | 17.37M | 77.46M | 117.86M |
Low Estimate | 9.00M | 9.60M | 38.30M | 46.40M |
Year ago Sales | 12.19M | 10.06M | 38.03M | 49.39M |
Year over Year Growth Est. | -7.59% | 21.75% | 29.88% | 37.81% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.17 | -0.66 | -0.70 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.13 | -0.13 | -0.54 | -0.55 |
High Estimate | -0.13 | -0.13 | -0.54 | -0.55 |
Low Estimate | -0.25 | -0.25 | -1.01 | -0.98 |
Year ago EPS | -0.14 | -0.11 | -0.51 | -0.66 |
Year over Year Growth Est. | -14.29% | -54.55% | -29.41% | -6.06% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.17 | -0.66 | -0.70 |
7 Days Ago | -0.16 | -0.17 | -0.66 | -0.70 |
30 Days Ago | -0.16 | -0.16 | -0.65 | -0.69 |
60 Days Ago | -0.16 | -0.16 | -0.65 | -0.69 |
90 Days Ago | -0.12 | -0.13 | -0.60 | -0.66 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.13 | -0.13 | -0.54 | -0.55 |
Zacks Consensus Estimate | -0.16 | -0.17 | -0.66 | -0.70 |
Earnings ESP | 20.73% | 21.69% | 18.43% | 21.65% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.17 | -0.10 | -0.11 | -0.14 | NA |
Estimate | -0.14 | -0.14 | -0.13 | -0.12 | NA |
Difference | -0.03 | 0.04 | 0.02 | -0.02 | 0.00 |
Surprise | -21.43% | 28.57% | 15.38% | -16.67% | 1.46% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more